These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 18679384)
1. Is activation of coronary venous cells the key to cardiac regeneration? Mohl W; Mina S; Milasinovic D; Kasahara H; Wei S; Maurer G Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):528-30. PubMed ID: 18679384 [No Abstract] [Full Text] [Related]
2. Use of erythropoietin for cardiovascular protection. Bahlmann FH Cardiovasc Drugs Ther; 2008 Aug; 22(4):253-5. PubMed ID: 18500549 [No Abstract] [Full Text] [Related]
3. The cardiovascular unit as a dynamic player in disease and regeneration. Ausoni S; Sartore S Trends Mol Med; 2009 Dec; 15(12):543-52. PubMed ID: 19913457 [TBL] [Abstract][Full Text] [Related]
4. the coronary venous system: an alternative route of access to the myocardium. Jain AK; Smith EJ; Rothman MT J Invasive Cardiol; 2006 Nov; 18(11):563-8. PubMed ID: 17090824 [TBL] [Abstract][Full Text] [Related]
12. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Sekine H; Shimizu T; Hobo K; Sekiya S; Yang J; Yamato M; Kurosawa H; Kobayashi E; Okano T Circulation; 2008 Sep; 118(14 Suppl):S145-52. PubMed ID: 18824746 [TBL] [Abstract][Full Text] [Related]
13. Cellular reprogramming: a new avenue to cardiac regeneration? White AJ; Arasaratnam D; Elliott DA; Kaye DM Circ Heart Fail; 2013 Sep; 6(5):1102-7. PubMed ID: 24046477 [No Abstract] [Full Text] [Related]
14. The origin of fibroblasts and mechanism of cardiac fibrosis. Krenning G; Zeisberg EM; Kalluri R J Cell Physiol; 2010 Nov; 225(3):631-7. PubMed ID: 20635395 [TBL] [Abstract][Full Text] [Related]
15. The challenges for cardiac vascular precursor cell therapy: lessons from a very elusive precursor. Roura S; Gálvez-Montón C; Bayes-Genis A J Vasc Res; 2013; 50(4):304-23. PubMed ID: 23860201 [TBL] [Abstract][Full Text] [Related]
16. Potential use of endothelial progenitor cells for regeneration of the vasculature. Yamahara K; Itoh H Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668 [TBL] [Abstract][Full Text] [Related]
17. Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data. Gathier WA; van Ginkel DJ; van der Naald M; van Slochteren FJ; Doevendans PA; Chamuleau SAJ J Cardiovasc Transl Res; 2018 Jun; 11(3):173-181. PubMed ID: 29392536 [TBL] [Abstract][Full Text] [Related]
18. New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature. Michelis KC; Boehm M; Kovacic JC Stem Cell Res; 2014 Nov; 13(3 Pt B):666-82. PubMed ID: 24841067 [TBL] [Abstract][Full Text] [Related]
19. Current concepts and applications of coronary venous retroinfusion. Boekstegers P; Kupatt C Basic Res Cardiol; 2004 Nov; 99(6):373-81. PubMed ID: 15503084 [TBL] [Abstract][Full Text] [Related]
20. Do Thebesian veins and arterioluminal vessels protect against myocardial edema occurrence? Kurbel S; Marić S; Gros M Med Hypotheses; 2009 Jul; 73(1):38-9. PubMed ID: 19264425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]